Three hundred twenty-nine strains of the tribe Klebsielleae were compared by several biochemical tests and by susceptibility to selected antibiotics. Biochemical tests included urease, amino acid decarboxylase, and hydrogen sulfide production; fermentation of lactose and dextrose; motility; and tests in the IMViC (indole, methyl red, Voges-Proskauer, citrate) series. The isolates were: Klebsiella species, 67.5 %; Enterobacter species, 28 %, and Serratia species, 4.5 %. Minimal inhibitory concentrations of cephaloridine, cephalothin, and a new cephalosporin, cephalexin, and of ampicillin were determined by the agar dilution procedure. Cephalosporins at 20 ug/ml or less inhibited 90% of the Klebsiella strains but only 15% of the Enterobacter strains. Ampicillin inhibited 27% of Enterobacter strains and 17% of Kiebsiella strains. Serratia isolates were insensitive to the cephalosporins and ampicillin. The results suggest that precise identification of this group to the generic level can be accomplished readily in the clinical laboratory and that such information is helpful in the preliminary selection of an antibiotic for treatment of clinical infections.
creasing importance of gram-negative bacteria as causes of clinically important infections, and the conflicting reports pertaining to the susceptibility of organisms of this group (2, 8, 16, 17) to certain antibiotics prompted us to evaluate the biochemical characteristics and the antibiotic susceptibility of members of the tribe Klebsielleae isolated in the Mayo Clinic laboratories.
For many years the appearance of the colonies of the lactose-fermenting Enterobacteriaceae on eosin-methylene blue-agar has been a primary basis for identifying and separating the "colonaerogenes" group. This method readily distinguishes Escherichia coil from the KlebsiellaEnterobacter-Serratia group of bacteria with a high degree of accuracy, but it provides no means of identifying atypical strains and it fosters the lumping of organisms into a broad, ill-defined group. The suggestions of Lampe (18) and Thaler (22) , that these organisms cause similar infections requiring similar treatment and therefore the use of complicated and lengthy laboratory procedures for separation and differentiation is not warranted, are no longer acceptable. The introduction of new antibiotics and chemotherapeutic agents with a wide range of effectiveness against certain gram-negative bacteria, particularly ampicillin and the cephalosporins, has made it necessary to identify infecting organisms as precisely as possible. For example, ampicillin is usually effective against E. coil and Proteus mirabilis strains but not against Kleb- siella, Enterobacter, Serratia, or Providencia species (1) . Similarly, the report by Fleming and associates (15) , that Klebsiella species are sensitive to cephalothin but Aerobacter (Enterobacter) species are not (because of the production of a cephalosporinase by the latter), suggests that it is important for the clinical laboratory to provide accurate bacterial identification.
Our study was undertaken to determine (i) the frequency of isolation and (ii) the susceptibility to selected antibiotics of members of the tribe Klebsielleae in material presented to the clinical laboratory of the Mayo Clinic. In addition, biochemical tests used for the classification were evaluated in the clinical laboratory setting. The primary group of antibiotics chosen for this study were the cephalosporins, of which one has given conflicting results (2, 4, 6, 8, 16, 17, 20 Lerner and Weinstein (20) . Table 2 shows the distribution of the positive reactions in the basic biochemical tests. Twentyeight Klebsiella strains (13%) varied from the typical or definitive reactions of the genus (indole-negative, citrate-positive, ornithine-decarboxylase-negative, lysine-decarboxylase-positive, nonmotile). The significant variances were in the results for indole production (3%), citrate The results of the biochemical tests of the 15 strains of Serratia are similar to those reported in the literature, even though only a small number of strains were examined. All strains were incubated for 3 days at 22 C on nutrient agar for pigment production, but only two strains produced prodigiosin. None of these strains fermented rhamnose, raffinose, or arabinose.
Antibiotic sensitivity. Table 3 shows the distribution of MIC for the four antibiotics tested. Of the Klebsiella strains, 57% or greater were inhibited by each of the three cephalosporins at 5 ,g/ml. Most of the remaining strains were inhibited by either 10 or 20 jig/ml of these same antibiotics. Higher concentrations of ampicillin were needed to inhibit the Klebsiella strains, and greater variability in antibiotic susceptibility was noted. Only 37 strains (17%) were inhibited by 20 Ag/ml or less, and 64 strains (29%) were not inhibited by 200 ,ug/ml.
The Enterobacter strains exhibited the same susceptibility pattern to ampicillin as did the Klebsiella strains, 27% of the strains being inhibited by concentrations of 20 Ag/ml or less.
However, these strains differed markedly from the Klebsiella strains in susceptibility to the cephalosporins. Only six (7%) Enterobacter strains were inhibited by any of the three cephalosporin antibiotics at 5 ,ug/ml, and large numbers The terms "resistant" and "sensitive" as used here are interpretations of in vitro tests. No implication is made as to the actual clinical response of these organisms to the antibiotics tested. A "sensitive" organism was arbitrarily defined as one inhibited by any one of the antibiotics at a concentration of 20 jig/ml or less.
An average of 90% of the Klebsiella strains were sensitive to the cephalosporins, compared to only 15% of the Ezterobacter strains (Fig. 1) . Ampicillin appeared to be slightly more effective against Enterobacter strains than against Klebsiella strains.
The sensitivity of the Klebsiella and Enterobacter strains to the cephalosporin antibiotics was fairly uniform. If a strain was inhibited by one of these antibiotics, it was usually inhibited by the other two as well. However, a few strains were inhibited by one of the cephalcsporins but not the other two, or by two but not by the third. At the 20 Ag/ml level, only 22 strains exhibited this peculiarity (Table 4) . Consequently, there was a 90% chance that, if an organism was sensitive to one of the cephalosporins, it would be sensitive to the other two as well.
To avoid bias that may have been introduced by our interpretation of the results of the several biochemical tests, the atypical strains were ex- 18, 1969 on August 27, 2017 by guest http://aem.asm.org/ Downloaded from only 8% of the Enterobacter strains were negative. Routine use of both tests would eliminate errors in classification.
Although identification to the level of species could be achieved in the majority of instances by the tests used or by addition of one or two other tests, this information is not included since it was our purpose to indicate the ease of identification of the genera and to test antibiotic susceptibility differences inherent in these genera to the selected antibiotics. Speciation or serological typing would, of course, add to the epidemiological value of the information obtained, but such an undertaking was beyond the intent of the study.
The frequency of isolation and the antibiotic sensitivity of members of the tribe Klebsielleae from clinical material vary among reported series (2, 4, 6, 8, 16, 20) . Klebisella isolates outnumber Enterobacter isolates. Lerner and Weinstein (20) The disparities in isolation rate and antibiotic sensitivity of Klebsiella and Enterobacter strains are difficult to explain but might be the result of differences in methods used in isolation and identification or in determination of antibiotic sensitivity of the organisms, or they might be a reflection of a bona fide difference in geographic distribution. It has also been suggested that organisms isolated from different specimens may have different antibiotic susceptibilities, at least in terms of the sensitivity of Klebsiella to cephalothin (16) . Consequently, comparisons between studies not specifying the source of isolation may not be completely valid.
Only two of our Serratia strains produced pigment, and reliance on the production of pigment for identification of Serratia is not recommended. The combination of motility and production of ornithine and lysine decarboxylases permitted the classification of Serratia strains without difficulty in most instances, but confirmation was provided by appropriate fermentative reactions in arabinose, rhamnose, and raffinose. Edwards and Ewing (7) reported pigmentation in only 26 % of their strains of Serratia. More recently, Fields et al. (12) described pigmentation in less than 10% of their clinical isolates of Serratia and also pointed out the resistance of these organisms to most antibiotics, findings corroborated in our study.
Before the availability of ampicillin there was little reason to differentiate organisms in the "colon-aerogenes" group because of the similarity in antibiotic susceptibility among members of this large heterogeneous group. Until cephalothin was made available, there was little reason to differentiate between Klebsiella and Enterobacter species except for epidemiological purposes. However, our study suggests that a distinct difference in antibiotic sensitivity does exist for members of this ubiquitous and genetically related group and that classification into genera by the clinical laboratory can be readily accomplished, providing useful information to the clinicians.
Of the Klebsiella species defined by our system, 90% were inhibited by low concentrations of the cephalosporin antibiotics, compared to only 15% of the Enterobacter strains. The differences in sensitivity between the various cephalosporins for the Klebsiella were small. Prior results (9) with the agar dilution procedure for antibiotic sensitivity testing indicate the reliability of the method, and repeated testing of the same or more strains would probably further minimize the differences. Our results most closely parallel those of Lerner and Weinstein (20) , both in the degree of sensitivity of Klebsiella isolates to cephalothin and in the frequency of isolation of Klebsiella strains from clinical material. The results of our study contrast sharply with those of Bulger (4) and Eickhoff and et al. (8) . By using a tube dilution procedure for determining antibiotic susceptibility, Bulger found that 53% of the Klebsiella strains were inhibited by cephalothin at 15 Ag/ml or less; Eickhoff et al. reported that 22% of Klebsiella strains were inhibited by cephalothin at 25 ,g/ml.
This lack of agreement could be the result of differences in methods of antibiotic sensitivity testing or in identification of the organisms. More likely, it represents one or a combination of several other factors. Benner et al. (2) suggested that the adaptive production of cephalosporinase by some strains of Klebsiella may be responsible for differences in antibiotic susceptibility patterns. The medical importance of infective drug resistance or resistance transfer factors was realized early by the Japanese (23) With the wider clinical application of cephalothin and, to a lesser extent, cephaloridine, increasing numbers of cephalosporin-resistant Klebsiella may be seen in the future. Although the cephalosporin-resistant strains in this study were not examined for the presence of resistance transfer factors or cephalosporinase activity, future studies could combine the efforts of the clinical microbiologist, the geneticist, the clinician, and the epidemiologist to evaluate the significance of these factors.
Proper bacteriological classification, as accomplished in the clinical laboratory, provides information for a better understanding of the taxonomic relationship of organisms and for epidemiological studies in tracing sources of infection. It can serve also as an aid to the clinician in the preliminary selection of an antibiotic for treatment. An understanding of the genetic capabilities of these organisms will also contribute to the taxonomy, epidemiology, and evaluation of antibiotic susceptibility. The actual treatment of the patient, however, should be based upon the accurate in vitro determination of the antibiotic susceptibility of the organism isolated in the clinical laboratory.
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